Applications of Multi-omics Analysis in Human Diseases
Overview
Authors
Affiliations
Multi-omics usually refers to the crossover application of multiple high-throughput screening technologies represented by genomics, transcriptomics, single-cell transcriptomics, proteomics and metabolomics, spatial transcriptomics, and so on, which play a great role in promoting the study of human diseases. Most of the current reviews focus on describing the development of multi-omics technologies, data integration, and application to a particular disease; however, few of them provide a comprehensive and systematic introduction of multi-omics. This review outlines the existing technical categories of multi-omics, cautions for experimental design, focuses on the integrated analysis methods of multi-omics, especially the approach of machine learning and deep learning in multi-omics data integration and the corresponding tools, and the application of multi-omics in medical researches (e.g., cancer, neurodegenerative diseases, aging, and drug target discovery) as well as the corresponding open-source analysis tools and databases, and finally, discusses the challenges and future directions of multi-omics integration and application in precision medicine. With the development of high-throughput technologies and data integration algorithms, as important directions of multi-omics for future disease research, single-cell multi-omics and spatial multi-omics also provided a detailed introduction. This review will provide important guidance for researchers, especially who are just entering into multi-omics medical research.
Metabolically Healthy Obesity Is Characterized by a Distinct Proteome Signature.
Mir F, Abdesselem H, Cyprian F, Iskandarani A, Doudin A, Shraim M Int J Mol Sci. 2025; 26(5).
PMID: 40076884 PMC: 11901089. DOI: 10.3390/ijms26052262.
Nantakeeratipat T, Fujihara C, Takedachi M Int J Mol Sci. 2025; 26(5).
PMID: 40076622 PMC: 11900451. DOI: 10.3390/ijms26051998.
Advancing Alzheimer's Therapy: Computational strategies and treatment innovations.
Paul J, Malik A, Azmal M, Gulzar T, Afghan M, Talukder O IBRO Neurosci Rep. 2025; 18:270-282.
PMID: 39995567 PMC: 11849200. DOI: 10.1016/j.ibneur.2025.02.002.
Mohan K, Ravichandran N, Rajendran H, Roshni J, Sivakumar M, Velayudam J ACS Omega. 2025; 10(5):4261-4275.
PMID: 39959106 PMC: 11822522. DOI: 10.1021/acsomega.4c05522.
Chen X, Li Y, Braconi D Front Cell Dev Biol. 2025; 13:1556129.
PMID: 39925740 PMC: 11802801. DOI: 10.3389/fcell.2025.1556129.